Imprimis Pharma Q2 results

|About: Imprimis Pharmaceutica... (IMMY)|By:, SA News Editor

Imprimis Pharmaceuticals (IMMY +2.3%) Q2 results: Revenues: $0.7M (+999%); Net Loss: ($2.6M) (-17.0%); Loss Per Share: ($0.28) (-12.0%); Quick Assets: $12.1M (-14.8%); Cash Burn: ($1.5M).

No financial guidance given.